Validations: Sampling/Acceptance Updates & Bridging

Guardbanding Specs After Change: Consumer Risk Lens

Guardbanding Specs After Change: Consumer Risk Lens Guardbanding Specs After Change: Consumer Risk Lens Understanding Change Control in Pharmaceutical Validation Change control is a critical component of pharmaceutical validation, ensuring that any modifications to manufacturing processes, equipment, or quality management systems do not adversely affect product quality or patient safety. This process is governed by regulations such as 21 CFR…

Continue Reading Guardbanding Specs After Change: Consumer Risk Lens

Bridging Studies: What Data Are Reusable

Bridging Studies: What Data Are Reusable In the pharmaceutical industry, effective change control mechanisms are vital to ensuring the safety, quality, and efficacy of medicinal products. Bridging studies are an essential part of this process, providing significant insights into what data can be reused during unique change scenarios. This tutorial aims to provide professionals with a structured approach to understanding…

Continue Reading Bridging Studies: What Data Are Reusable

Equivalence Testing: Stats That Justify No Re-Validation

Equivalence Testing: Stats That Justify No Re-Validation Equivalence Testing: Stats That Justify No Re-Validation In the regulated pharmaceutical industry, change control is a critical component that ensures quality and compliance throughout the product lifecycle. The definition of when re-validation is necessary can often pose challenges due to complex regulatory requirements and varying interpretations. This comprehensive guide aims to provide a…

Continue Reading Equivalence Testing: Stats That Justify No Re-Validation

Sampling Updates After Change: Attribute vs Variable Choices

Sampling Updates After Change: Attribute vs Variable Choices Sampling Updates After Change: Attribute vs Variable Choices In today’s pharmaceutical industry, rigorous compliance with regulatory standards is paramount. Change control procedures are essential for ensuring that any alterations in processes or products do not adversely affect quality, safety, and efficacy. This guide outlines a comprehensive approach to sampling updates following change…

Continue Reading Sampling Updates After Change: Attribute vs Variable Choices

Re-Establishing AQL/Cpk: How Much Evidence Is Enough

Re-Establishing AQL/Cpk: How Much Evidence Is Enough Re-Establishing AQL/Cpk: How Much Evidence Is Enough In today’s regulatory environment, particularly concerning the pharmaceutical sector, conducting a thorough change control impact assessment is crucial for ensuring the continued efficacy and safety of pharmaceutical products. This article provides a step-by-step guide focused on verification versus re-validation, exploring risk-based change thresholds, bridging studies, and…

Continue Reading Re-Establishing AQL/Cpk: How Much Evidence Is Enough

Visual/AIS Sampling Changes: Sensitivity and False Rejects

Visual/AIS Sampling Changes: Sensitivity and False Rejects The pharmaceutical industry has a rigorous set of quality assurance and compliance regulations that ensure product safety and efficacy. Within this framework, understanding how to manage change control, particularly in the context of visual and automated inspection system (AIS) sampling changes, is critical for maintaining compliant production processes. This article serves as a…

Continue Reading Visual/AIS Sampling Changes: Sensitivity and False Rejects

Analytical LOQ vs Product Specs: Ensuring Sensitivity

Analytical LOQ vs Product Specs: Ensuring Sensitivity Analytical LOQ vs Product Specs: Ensuring Sensitivity Introduction to Change Control in Pharmaceutical Validation Change control is an essential component of pharmaceutical quality systems, particularly in the context of validation activities. The purpose of a change control process is to manage and document significant changes that may affect the quality and compliance of…

Continue Reading Analytical LOQ vs Product Specs: Ensuring Sensitivity

Common Sampling/Bridging Errors—and Fixes

Common Sampling/Bridging Errors—and Fixes In the highly regulated pharmaceutical industry, maintaining compliance with cGMP guidelines is critical for ensuring product quality and safety. One area that often presents challenges is the handling of sampling and bridging errors, particularly in the context of change control impact assessments, verification versus re-validation, and other critical processes. This guide aims to provide pharmaceutical professionals…

Continue Reading Common Sampling/Bridging Errors—and Fixes

Templates: Post-Change Sampling Plans

Templates: Post-Change Sampling Plans Templates: Post-Change Sampling Plans Introduction to Change Control and Sampling Plans Change control is a fundamental aspect of compliance in the pharmaceutical industry, influencing both product quality and regulatory adherence. It ensures that changes to processes, equipment, or systems are properly documented, evaluated for impact, and controlled in accordance with regulatory requirements such as 21 CFR…

Continue Reading Templates: Post-Change Sampling Plans

RTRT/PAT: Multivariate Bridges

RTRT/PAT: Multivariate Bridges RTRT/PAT: Multivariate Bridges In the ever-evolving world of pharmaceuticals, the regulatory landscape is continually shaped by advancements in science and technology. Real-Time Release Testing (RTRT) and Process Analytical Technology (PAT) provide frameworks that facilitate more adaptive methods to control production processes. One critical component of achieving compliance in pharmaceutical manufacturing is the change control process. This article…

Continue Reading RTRT/PAT: Multivariate Bridges